PULM
PULM
NASDAQ · Pharmaceuticals

Pulmatrix Inc

$1.50
-0.04 (-2.60%)
As of Jun 23, 10:16 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +202.7% upside
Low Target $3.16
Average Target $4.54
High Target $6.69
Current Price $1.50
Current
$1.50
Target
$4.54
$3.16 $4.54 avg $6.69
Scenario Analysis
Bear Case
$3.16
110.7%
Low target
Base Case
$4.54
+202.7%
Avg target
Bull Case
$6.69
+346.0%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$9.15
-83.6% from high
52-Week Low
$1.16
+29.3% from low
Target vs 52W High
$4.54
-50.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%